Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Metabolic Syndrome in Older Adults
NCT03193944Phase 2Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cholecalciferol in Vitamin D deficiency (VDD) and metabolic syndrome (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Achieving 25 (OH) D upper than insufficient serum 25(OH) D level >30 ng/l at 2 months. Started Feb 2017; status: completed.
02
Drugs
cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)metabolic syndrome
Beyond the preview
Go deeper on NCT03193944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03193944.